Literature DB >> 2382679

Serum soluble interleukin-2 receptor in patients with glomerulonephritis.

N Yorioka1, A Hirabayashi, K Kanahara, A Takemasa, H Oda, Z H Joarder, M Yamakido.   

Abstract

Serum soluble interleukin-2 receptor (IL-2R) concentrations were determined using the ELISA method in 55 cases of glomerulonephritis. These patients can be classified as 29 cases of IgA nephropathy, 10 cases of membranous glomerulonephritis and 16 cases of mesangial proliferative glomerulonephritis. Our results showed that serum soluble IL-2R concentrations in glomerulonephritis cases were significantly higher than those in healthy controls. Among the different types of glomerulonephritis cases, however, no significant differences in serum soluble IL-2R were observed. While we found a significant positive correlation of serum soluble IL-2R to BUN and creatinine, we also found a significant negative correlation between serum soluble IL-2R and creatinine clearance. These findings suggest that serum soluble IL-2R can serve as an indicator of exacerbation of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2382679     DOI: 10.1159/000168078

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  4 in total

Review 1.  T cell subsets in glomerular diseases.

Authors:  S Florquin; M Goldman
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Soluble interleukin-2 receptor in patients with glomerular diseases.

Authors:  H S Chen; M S Wu; T S Yen; W Y Chen
Journal:  Postgrad Med J       Date:  1995-10       Impact factor: 2.401

3.  Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome.

Authors:  S A Hulton; V Shah; M R Byrne; G Morgan; T M Barratt; M J Dillon
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

4.  Soluble Interleukin-2 Receptor Predicts Treatment Outcome in Patients With Autoimmune Tubulointerstitial Nephritis. A Preliminary Study.

Authors:  Satoka Shiratori-Aso; Daigo Nakazawa; Saori Nishio; Yusho Ueda; Mina Eguchi; Ai Yokoyama; Junpei Yoshikawa; Takashi Kudo; Kanako Watanabe-Kusunoki; Sayo Takeda-Otera; Junya Yamamoto; Naoko Matsuoka; Nobuharu Kaneshima; Fumihiko Hattanda; Sari Iwasaki; Takahiro Tsuji; Yuichiro Fukasawa; Tatsuya Atsumi
Journal:  Front Med (Lausanne)       Date:  2022-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.